Page last updated: 2024-11-02

phentermine and Chronic Insomnia

phentermine has been researched along with Chronic Insomnia in 3 studies

Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.

Research Excerpts

ExcerptRelevanceReference
" Importantly, the appetite suppressant-induced weight loss and locomotion were markedly reduced by intragastric (and intra-NAc shell) infusions of dopamine antagonists SCH-23390 (D1 receptor) or raclopride (D2 receptor)."3.81D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell. ( Elias, D; Gutierrez, R; Kalyanasundar, B; Luna, A; Moreno, MG; Perez, CI; Simon, SA; Solorio, J, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalyanasundar, B1
Perez, CI1
Luna, A1
Solorio, J1
Moreno, MG1
Elias, D1
Simon, SA1
Gutierrez, R1
Truant, AP1
Olon, LP1
Cobb, S1
Lobato, DS1
da Silveira, DD1

Trials

1 trial available for phentermine and Chronic Insomnia

ArticleYear
Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Current therapeutic research, clinical and experimental, 1972, Volume: 14, Issue:11

    Topics: Adult; Age Factors; Appetite Depressants; Body Weight; Clinical Trials as Topic; Constipation; Diet,

1972

Other Studies

2 other studies available for phentermine and Chronic Insomnia

ArticleYear
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
    Journal of neurophysiology, 2015, Volume: 114, Issue:1

    Topics: Action Potentials; Animals; Appetite Depressants; Benzazepines; Bupropion; Diethylpropion; Dopamine

2015
[Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
    Hospital (Rio de Janeiro, Brazil), 1966, Volume: 70, Issue:5

    Topics: Appetite Depressants; Constipation; Drug Tolerance; Headache; Humans; Obesity; Phenethylamines; Phen

1966